TOP 100 MEDICAL SITES
| |||
|
| |||
| |||
|
| |||
| What Lies Ahead for Javelin Pharmaceuticals? CVTrader submits:Javelin Pharmaceuticals (JAV) is a specialty pharmaceutical company with a focus in the pain management market. Their primary technical innovations are improved formulations of existing drugs. Javelin has one marketed product - Dyloject - in the UK. In the US, it has submitted a New Drug Application (NDA) for Dyloject and has two drug candidates in Phase III clinical development: Ereska (intranasal ketamine) and Rylomine (intranasal morphine). Its stock price has been in wild swings in the last several months because of its involvement in two M/A activities. Late last December, Myriad Pharmaceuticals (MYRX) entered into an agreement to merger with Javelin. But in April shortly before the closing date, Javelin struck a better deal with Hospira (HSP) for an all-cash acquisition of $2.20 per share (~$145M in value with a ~60% premium over its closing price). However, things are not all rosy from there for Javelin share holders. On May 19th, Hospira announced that it is extending the tender offer for another 2 weeks because certain conditions were not fully satisfied prior to the expiration of the initial offering period. Understandably, Javelin's stock price dropped ~40% at the start of the day. But that's not all; five days later, Javelin announced that its UK partner, Therabel Pharma which licensed the commercial rights to Dyloject in the European Union, is withdrawing the product from the UK market because of the presence of a white particulate matter in some vials of Dyloject in its supply chain. It appears to be a bigger blow to Javelin and its stock price dropped to as low as $1.15, but it soon bounced back to as high as $1.77 the day before the deadline of the extended tender offer.Complete Story » seekingalpha.com |
U.S. Tan Tax Burns Some Badly A tax on tanning services will be the first tax to take effect in the health-care overhaul. But not all tans are taxed. Those offered by health-care clubs often aren't, and spray tans aren't. online.wsj.com |
FDA to Inspect Egg Producers The FDA will conduct hundreds of inspections of egg producers to ensure they adhere to newly implemented safety rules in the wake of the massive egg recall linked to a salmonella outbreak. online.wsj.com |
Windhover Information Names D-Tagatose One of Top 10 Most Promising CV/Metabolic Drugs in Development [PR Newswire] - Spherix Incorporated , an innovator in biotechnology for therapy in diabetes, metabolic syndrome, and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that the Company's pharmaceutical product, D-tagatose, has been selected as one of the top 10 most promising cardiovascular/metabolic therapies in development. Â The selection was made by an independent committee assembled by Windhover Information, a leading provider of business information products and services to senior executives in the pharmaceutical, biotechnology, and medical device industries and publisher of IN VIVO and Start-Up. Â Spherix has been invited to present its data on D-tagatose at Windhover's Therapeutic Alliances Cardiovascular Conference in Boston on November 3-4, 2010. us.rd.yahoo.com |
Hank Aaron Gets Back in the Game - Video Baseball Legend Hank Aaron Encourages People Struggling with Osteoarthritis of the Knee to Get Back in the Game feedproxy.google.com |